Navigation Links
Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
Date:5/17/2011

ATLANTA, May 17, 2011 /PRNewswire/ -- Inhibikase Therapeutics, Inc. today announced the election Dr. Steven C. Gilman to the Board of Directors of Inhibikase Therapeutics, Inc.

(Logo: http://photos.prnewswire.com/prnh/20110517/CL02791LOGO)

Dr. Steven Gilman joined Cubist Pharmaceuticals in 2008 and currently serves as the Cubist's Executive Vice President, Research & Development and Chief Scientific Officer. Before joining Cubist Pharmaceuticals, Dr. Gilman held several positions with ActivBiotics, Inc., including Chairman of the board of directors and President and CEO. Previously Dr. Gilman worked at Millennium Pharmaceuticals, Inc., where he held a number of senior leadership roles including Vice President and General Manager, Inflammation. Additionally, Dr. Gilman served as Group Director at Pfizer Global Research and Development, where he was responsible for drug discovery of novel antibacterial agents as well as several other therapeutic areas.

Dr. Gilman currently serves on the Boards of Directors of the Massachusetts Biotechnology Association and the Massachusetts Society for Medical Research. In addition, Dr. Gilman serves on the Science and Regulatory Executive Committee of PhRMA. Dr. Gilman received his Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio.

Dr. Gilman joins Board members Dr. Stephen Fesik, Orrin H. Ingram, II Chair in Cancer Research at Vanderbilt University and former Vice-President for Cancer Research, Abbott Laboratories, Mr. David Gryska, former CFO of Celgene and Ms. Lisa Evren, Vice-President and Treasurer, Talisman-Energy.

"We are fortunate to add Dr. Gilman to the slate of new Board members elected in the last eight months.  Dr. Gilman's breadth of experience in pharmaceutical development and senior leadership will acceler
'/>"/>

SOURCE Inhibikase Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
2. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
3. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
4. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
5. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
6. Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
7. Echo Therapeutics Expands Into New Headquarters in Philadelphia
8. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
9. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
10. Amicus Therapeutics Announces First Quarter 2011 Financial Results and Continued Progress of Development Programs
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DENVER , June 18, 2013  Healthgrades, ... evaluate, compare and connect with physicians and hospitals, ... 2013: "Lean in" When Making Healthcare Decisions to ... the best performing hospitals for maternity care, gynecologic ... the treatment of women across 15 of the ...
(Date:6/18/2013)... RIDGE, N.J. , June 18, 2013  Pro ... Adrian Peterson and professional family expert Jo ... partnering with Mylan Specialty L.P., the fully integrated specialty ... ), to raise awareness of this significant health problem. ... the U.S. Food and Drug Administration (FDA) approval of ...
(Date:6/17/2013)... 17, 2013 Vanda Pharmaceuticals Inc. (Vanda) ... today at ENDO 2013, the Endocrine Society,s 95 ... entrain (synchronize) both melatonin and cortisol rhythms. This ... master body clock and address the circadian desynchrony ... SET (Safety and Efficacy of Tasimelteon) and RESET ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
... 2007 - Cytogen,Corporation (NASDAQ: CYTO) today reported ... 2007 Annual Meeting of the American,Association for ... Angeles,California April 14-18, 2007. The AACR abstracts ... approaches to drug,discovery and development embodied in ...
... DIEGO, March 29, 2007 /PRNewswire-FirstCall/ -- ... and,development company focused on commercializing proprietary ... and infectious diseases,announced today that results ... combination with intravenous 5-fluorouracil (5-FU),and capecitabine ...
Cached Medicine Technology:Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 2ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,Meeting 3
(Date:6/18/2013)... Alto, CA (PRWEB) June 18, 2013 Palo ... be one of America's greenest cities with its recent major ... Council authorized three major solar electric power purchase agreements ... to 182,500 megawatt-hours (MWh) of solar photovoltaic electric power per ... the City’s electric needs. That’s enough power to supply ...
(Date:6/18/2013)... June 18, 2013 Internationally acclaimed ... new website, thebestbreast.com, showcasing his unique approach to ... information about his surgical method and highlights the ... on his website, Dr. Tebbetts compares his breast ... methods, Dr. Tebbetts’ method does not necessitate the ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network between ... broken, could cut off cancer cell growth at its ... The University of Texas MD Anderson Cancer Center reported ... well-known cancer drug target, and MCM7, a protein vital ... June issue of Cancer Cell . , "MCM7 ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... employees on Health Reimbursement Accounts . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, employees of a ... Account (HRA) may have questions about how Health Reimbursement ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2
... personal music players , , SATURDAY, Feb. 9 (HealthDay News) -- ... American youngsters have noise-induced hearing loss, something that,s entirely preventable, ... launched a public education campaign, called Turn it to the ... it can be prevented simply by turning down the volume ...
... (Nasdaq: AHPI ) reported today that its net income ... from $293,000 last year,or 4 cents per share, to about ... For the first half of the 2008 fiscal year ending ... last year, or six cents,per share, to about $93,500, or ...
... (Nasdaq:,EVVV), a global endovascular device company, today announced the,resignation ... Scientist and,from the company,s board of directors effective February ... people have shaped the treatment of,cardiovascular disease as much ... for improving the lives of patients worldwide," said,Jim Corbett, ...
... Mesa Laboratories,Inc. (Nasdaq: MLAB ) today ... regular quarterly cash dividend of ten cents per ... to shareholders of record at the close of,business ... acquires, manufactures and markets,electronic instruments for industrial, pharmaceutical ...
... profit margin increases; net loss ... remains stable - ... noted), BELLEVILLE, ON, Feb. 8 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... second,quarter of its 2008 fiscal year, ending December 31, 2007., "The ...
... the Status Quo to Advance,Health Care Reform, ... the,Robert Wood Johnson Foundation,s State Coverage Initiatives program, ... outlines 2007 efforts to,expand health insurance coverage and ... the state level. While many states made progress, ...
Cached Medicine News:Health News:Campaign Targets Noise-Induced Hearing Loss in Kids 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 3Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 4Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 2Health News:Bioniche Reports Fiscal 2008 Second Quarter 3Health News:Bioniche Reports Fiscal 2008 Second Quarter 4Health News:Bioniche Reports Fiscal 2008 Second Quarter 5Health News:Bioniche Reports Fiscal 2008 Second Quarter 6Health News:Bioniche Reports Fiscal 2008 Second Quarter 7Health News:Bioniche Reports Fiscal 2008 Second Quarter 8Health News:Bioniche Reports Fiscal 2008 Second Quarter 9Health News:Bioniche Reports Fiscal 2008 Second Quarter 10Health News:Bioniche Reports Fiscal 2008 Second Quarter 11Health News:Bioniche Reports Fiscal 2008 Second Quarter 12Health News:Bioniche Reports Fiscal 2008 Second Quarter 13Health News:Bioniche Reports Fiscal 2008 Second Quarter 14Health News:Report Lists Key Policy Questions Facing State, National Health Reform 2Health News:Report Lists Key Policy Questions Facing State, National Health Reform 3Health News:Report Lists Key Policy Questions Facing State, National Health Reform 4
... Be Set To Any Degree Interval For Marking ... Outer Diameter Opposing Radials Accommodate All Astigmatic Incisions., ... For AKs, LRIs Or Peripheral Corneal Incisions At ... Paired AKs, LRIs Or Peripheral Corneal Incisions 360 ...
... Unique Reversible Speculums Designed To ... By Flipping The Speculums Over, Allowing ... Palpebral Fissures To The Widest Possible ... Operation, Providing Unobstructed Around-The-Clock Access To ...
... The Forceps Are Available In Two Models: ... Are Compressed, The Jaws Close. The Other ... The Handles Are Compressed The Jaws Open., ,The ... To Be Inserted Through A 1.1mm Incision. These ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
Medicine Products: